It’s not every day you get to partner with a genius scientist and a self-made billionaire. Mark Bamforth OBE, Dr. Richard Snyder, and Nigel Walker founded disAMR to combat the ever-challenging topic of Anti-Microbial Resistance. This new platform is the first operating role Nigel has taken on since starting That’s Nice more than 30 years ago.
disAMR has acquired AMR Insights and will look to build upon the foundation Maarten developed eight years ago.
Luke Walker was spotted on the scene, for the first time in nearly two decades, removing more than a foot of snow that NYC received yesterday.
We’re pleased to announce the launch of disAMR (formerly AMR Insights). disAMR, pronounced “disarm” as it is committed to combating the threat of AMR, will serve as a nexus for AMR communications, education, and advocacy—connecting stakeholders, promoting innovation, shaping policy, and supporting sustainable antimicrobial product development. Learn more at www.disamr.com.
Sarah’s giving her best mean mug. She’d fit right in with the best of them at Shawshank.
The Lunar New Year is upon us. Our friends at Wilmington PharmaTech wish everyone a prosperous new year.
Another shot of Prof. Dan Smith’s presentation at ATW 2026. Did you know that most of the info in this presentation was sourced directly from Nice Insight’s 2026 State of the Industry Report? The open-access report is available for download right now on www.PharmasAlmanac.com.
At Advanced Therapies Week in San Diego, we were honored to secure a speaking slot, where our CSO, Dan, presented on key trends shaping the advanced therapies CDMO landscape.
Nigel, Dan, and the rest of the gang cheesing it up at Advanced Therapies Week in San Diego.
Spy shot of the driveway getting cleared from the Ring Doorbell.